15 Large-cap Stocks with Highest Dividends
Large-cap stocks are usually issued by established companies with long track records. These are often well-known names that have been operating for years.
Sanofi Aventis (SNY)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 12,140,615 | $588,334,216 | -4% | 0.2% |
| 2. | VGI Partners Robert M. P. Luciano | 1,911,650 | $92,638,559 | +16% | 5.34% |
| 3. | Citadel Investment Group Ken Griffin | 1,252,536 | $60,697,895 | +63% | 0.01% |
| 4. | Sio Capital Michael Castor | 971,686 | $47,087,904 | +73% | 7.41% |
| 5. | Armistice Capital Steven Boyd | 676,000 | $32,758,960 | +11% | 0.39% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,094,962 | $100,165,953 | 0.54% | |
| 2. | 115,341 | $5,557,145 | 0.04% | |
| 3. | 106,888 | $5,118,845 | 0.01% | |
| 4. | 83,067 | $4,002,168 | 0.48% | |
| 5. | 75,027 | $3,614,801 | 0.47% |
News See All
FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports
Sanofi (NASDAQ:SNY) is one of the best undervalued stocks under $50 to invest in now. Sanofi (NASDAQ:SNY) announced on March 18 that the US Food and Drug Administration (FDA) has granted Breakthrough...
15 Best Undervalued Stocks Under $50 to Invest In Now
On March 20, Tom Lee, Fundstrat, appeared on CNBC's ‘Power Lunch’ to talk about his price target for the S&P and the potential of the market to rise higher.
Sanofi (SNY) and Regeneron’s Dupixent Recommended for EU Approval
Sanofi (NASDAQ:SNY) is one of the best cheap stocks under $50 to buy right now.
15 Cheap Stocks Under $50 to Buy Right Now
On February 26, Ed Yardeni, Yardeni Research president, appeared on CNBC’s 'Closing Bell' to talk about his thoughts on the tech trade and the market's standings.
Sanofi's (SNY) R&D Track Record Remains Investor Concern, Says BofA
TheFly reported that on February 20, SNY’s price target was lowered at Citi by EUR 5.
7 Oversold Pharma Stocks to Buy Now
In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected to have grown to $883.97 billion.
Manuela Buxo To Become Head of Sanofi's (SNY) Specialty Care Global Business Unit
Sanofi (NASDAQ:SNY) is one of the Best Dip Stocks to Buy According to Hedge Funds.
11 Best Dip Stocks to Buy According to Hedge Funds
On February 17, Mohamed El-Erian, Chief Economic Advisor at Allianz, appeared on a CNBC Television interview to discuss the way forward amidst the volatility.
Is Sanofi (SNY) One of the Best Healthcare Stocks Under $50 to Invest In?
Sanofi (NASDAQ:SNY) is one of the best healthcare stocks under $50 to invest in. Kepler Capital maintained a Hold on Sanofi (NASDAQ:SNY) on February 3 with a price target of €85.